GJB2 and KID syndrome: To validate the efficacy of abEC1.1 for the treatment of KID syndrome caused by hyperactive Cx26 mutant channels, Peres et al. employed adeno-associated virus-mediated abEC1.1 monoclonal antibody gene transfer treatment in the mouse model.